JSPR logo

Jasper Therapeutics (JSPR) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$71.64 M
-$15.25 M-17.55%

December 31, 2024


Summary


Performance

JSPR Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherJSPRbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$71.64 M
-$20.86 M-22.56%

December 31, 2024


Summary


Performance

JSPR Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherJSPRbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

JSPR Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.6%0.0%
3 y3 years-15.4%-31.0%
5 y5 years+261.1%-31.0%

JSPR Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-17.6%+87.3%-44.6%+87.3%
5 y5-year-17.6%+261.1%-44.6%+261.1%
alltimeall time-17.6%+261.1%-44.6%+261.1%

Jasper Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$71.64 M(-17.6%)
$71.64 M(-22.6%)
Sep 2024
-
$92.50 M(-13.4%)
Jun 2024
-
$106.82 M(-9.8%)
Mar 2024
-
$118.47 M(+36.4%)
Dec 2023
$86.89 M
$86.89 M(-16.3%)
Sep 2023
-
$103.87 M(-10.3%)
Jun 2023
-
$115.81 M(-10.5%)
DateAnnualQuarterly
Mar 2023
-
$129.40 M(+238.3%)
Dec 2022
$38.25 M(-54.8%)
$38.25 M(-24.9%)
Sep 2022
-
$50.95 M(-16.2%)
Jun 2022
-
$60.81 M(-13.6%)
Mar 2022
-
$70.40 M(-16.9%)
Dec 2021
$84.70 M(+327.0%)
$84.70 M(-16.1%)
Sep 2021
-
$100.91 M(+408.6%)
Dec 2020
$19.84 M
$19.84 M

FAQ

  • What is Jasper Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Jasper Therapeutics?
  • What is Jasper Therapeutics annual cash & cash equivalents year-on-year change?
  • What is Jasper Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Jasper Therapeutics?
  • What is Jasper Therapeutics quarterly cash and cash equivalents year-on-year change?

What is Jasper Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of JSPR is $71.64 M

What is the all time high annual cash & cash equivalents for Jasper Therapeutics?

Jasper Therapeutics all-time high annual cash & cash equivalents is $86.89 M

What is Jasper Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, JSPR annual cash & cash equivalents has changed by -$15.25 M (-17.55%)

What is Jasper Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of JSPR is $71.64 M

What is the all time high quarterly cash and cash equivalents for Jasper Therapeutics?

Jasper Therapeutics all-time high quarterly cash and cash equivalents is $129.40 M

What is Jasper Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, JSPR quarterly cash and cash equivalents has changed by $0.00 (0.00%)